The mechanism of NLRP3 inflammasome activation and its pharmacological inhibitors

Xiaoyan Zhan,Qiang Li,Guang Xu,Xiaohe Xiao,Zhaofang Bai
DOI: https://doi.org/10.3389/fimmu.2022.1109938
IF: 7.3
2023-01-19
Frontiers in Immunology
Abstract:NLRP3 (NOD-, LRR-, and pyrin domain-containing protein 3) is a cytosolic pattern recognition receptor (PRR) that recognizes multiple pathogen-associated molecular patterns (PAMPs) and damage-associated molecular patterns (DAMPs). Once activated, NLRP3 initiates the inflammasome assembly together with the adaptor ASC and the effector caspase-1, leading to caspase-1 activation and subsequent cleavage of IL-1β and IL-18. Aberrant NLRP3 inflammasome activation is linked with the pathogenesis of multiple inflammatory diseases, such as cryopyrin­associated periodic syndromes, type 2 diabetes, non-alcoholic steatohepatitis, gout, and neurodegenerative diseases. Thus, NLRP3 is an important therapeutic target, and researchers are putting a lot of effort into developing its inhibitors. The review summarizes the latest advances in the mechanism of NLRP3 inflammasome activation and its pharmacological inhibitors.
immunology
What problem does this paper attempt to address?